Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CPMA. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111433357B reveals high-ee enzymatic reduction for chiral alcohols, offering cost-effective and scalable supply chain solutions for pharmaceutical intermediates.
Patent CN108359649A reveals high-selectivity alcohol dehydrogenase mutants for synthesizing chiral biaryl alcohols, offering cost reduction and supply reliability.